Trailblazing Frontiers: A Year of Progress, Purpose, and a Brighter Future Ahead
Leaps by Bayer
Breaking through the impossible. Leaps by Bayer aims to conquer 10 huge challenges facing humanity.
February 2025
Discover the latest in life sciences with Leaps by Bayer. In this edition, we explore the latest biotech market developments, spotlight a recent milestone achieved by Leaps' portfolio company eGenesis, Inc. , and showcase our most recent publications. Don't miss our most trending podcast recommendations - a list compiled by Labiotech.eu .
Perspectives from the Inside/
5 Insights From The 2025 JP Morgan Healthcare Conference
In his latest Forbes article, Juergen Eckhardt , Head of Leaps by Bayer, explores 5 upcoming investment trends in biotech that will shape the future of our life science industry. From an uptake in deal flow, the dominance of AI, advancements in cell and gene therapies, and the rise of Chinese innovation - hear from Juergen Eckhardt how he forecasts the market to develop.
Portfolio Company News/
F.D.A Approves Studies of Pig Organ Transplants for Kidney Patients
We’re incredibly proud to share that our portfolio company, eGenesis, Inc. , alongside United Therapeutics Corporation , has reached a historic milestone. The FDA has approved clinical studies of genetically modified pig organ transplants for patients with kidney failure — a groundbreaking advancement that could revolutionize the future of organ transplantation and offers hope to millions of patients worldwide.
领英推荐
Leaps Publications/
Leaps Publishes its 2024 Annual Review
We're excited to share our Annual Review 2024, which summarizes our key portfolio company and brand achievements that helped us leap forward in healthcare and agriculture. Since our start in 2015, we expanded our portfolio to over 65+ companies with over $2 billion invested and executed 30+ new and follow-on investments just in the last year. Read an exclusive interview between Nobel laurate Shinya Yamanaka on the potential of induced pluripotent stem cells and more below.
Leaps Publications/
Leaps Publishes its Breakthrough Study in Collaboration with BCG ?
How do people around the world feel about breakthrough science? To find out, we partnered with 波士顿谘询公司 to conduct one of the largest surveys on global public sentiment towards transformative technology. Over 13,000 participants in 13 countries shared what they feel and think about AI in healthcare, cell and gene therapies, cultivated meat, and new genomic techniques in agriculture.?Which technologies generate the most positivity??
Top Recommendations/
Neele Piekarz , our Digital & Event Marketing Associate, encourages you to check out this list of biotech podcasts collected by Labiotech.eu , covering cutting-edge innovations, industry trends, and thought-provoking discussions with leaders in the field. From CRISPR breakthroughs to the latest in biotech investing, these podcasts are your go-to resource for staying connected to the pulse of the industry.